Amundi’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$361K Sell
20,614
-375
-2% -$4.95K ﹤0.01% 1777
2026
Q1
$345K Buy
20,989
+6,996
+50% +$172K ﹤0.01% 1693
2025
Q4
$400K Buy
13,993
+201
+1% +$5.45K ﹤0.01% 1553
2025
Q3
$408K Sell
13,792
-4,100
-23% -$112K ﹤0.01% 1383
2025
Q2
$540K Buy
+17,892
New +$529K ﹤0.01% 1358
2024
Q2
Sell
-3,117
Closed -$119K 2029
2024
Q1
$119K Hold
3,117
﹤0.01% 1736
2023
Q4
$226K Sell
3,117
-247
-7% -$16.7K ﹤0.01% 1601
2023
Q3
$229K Hold
3,364
﹤0.01% 1565
2023
Q2
$280K Sell
3,364
-778
-19% -$68.1K ﹤0.01% 1516
2023
Q1
$371K Sell
4,142
-3,545
-46% -$308K ﹤0.01% 1415
2022
Q4
$653K Buy
7,687
+1,966
+34% +$167K ﹤0.01% 1360
2022
Q3
$412K Buy
5,721
+3,471
+154% +$311K ﹤0.01% 1361
2022
Q2
$223K Buy
2,250
+175
+8% +$17.8K ﹤0.01% 1352
2022
Q1
$244K Sell
2,075
-467
-18% -$49.8K ﹤0.01% 1366
2021
Q4
$299K Sell
2,542
-121
-5% -$16.8K ﹤0.01% 1450
2021
Q3
$376K Buy
2,663
+796
+43% +$107K ﹤0.01% 1381
2021
Q2
$239K Buy
+1,867
New +$220K ﹤0.01% 1346

Other funds holding QDEL

Amundi's QDEL Position: Q2 2026 in Review

Amundi reduced its QuidelOrtho (QDEL) stake by 1.8% in Q2 2026, selling an estimated $4.95K and leaving 20,614 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #1777.

Amundi first reported a position in QDEL in Q2 2021 and has held it in 17 quarters since. The position peaked at $653K in Q4 2022. 246 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • Amundi held 20,614 shares of QuidelOrtho worth $361K as of Q2 2026.
  • Amundi sold 375 QuidelOrtho shares in Q2 2026, an estimated $4.95K.
  • QuidelOrtho made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1777 holding.
  • Amundi first reported a position in QuidelOrtho in Q2 2021 and has held it in 17 quarters since.
  • Amundi's QuidelOrtho position peaked at $653K in Q4 2022.
  • 246 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.